🟢 Senti Biosciences is trading 8.35% up in pre-market after announcing $4.5 million financing

Senti Biosciences is trading 8.35% up now at $0.37 after announcing $4.5 million in financing on September 4, 2026.

• The package includes a completed $2.0 million senior secured convertible-note sale and a new $2.5 million equity commitment from a Celadon Partners affiliate.
• The financing extends liquidity, while convertible-note funding may create dilution and financing-risk concerns.
• Related filings confirm Celadon-backed convertible-note financing supports corporate purposes and SENTI-202 development.